Toggle navigation
Home
Search
Services
Blog
Contact
About
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David James
Virginia Commonwealth University, Richmond, VA, United States
Search 4 grants from David Mokler
Search grants from Virginia Commonwealth University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium
A Promoter-Specific TFO Prevents Liver Fibrosis
3-Nitrotyrosine in Aging of Skeletal Muscle and Heart
Effectivess of Targeted Antismoking Communications
Professional Nurse Traineeship Program
Recently added grants:
Hormonal Regulation and Tumor Promotional Phenotypes of Semaphorin 7a in Breast Cancer
Impact of chromosomal instability on sensitivity to microtubule-targeting drugs in breast cancer
Shared Resource 14: Survey and Data Management
Investigating the Role of Adipocyte Lipolysis in Melanoma Progression
Shared Resource 15: Biostatistics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DA005260-02
Application #
3035089
Study Section
(DABA)
Project Start
1986-07-01
Project End
Budget Start
1986-07-01
Budget End
1986-12-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Related projects
NIH 1986
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
NIH 1985
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
Publications
Mokler, D J; Robinson, S E; Rosecrans, J A
(1987)
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Eur J Pharmacol 138:265-8
Comments
Be the first to comment on David Mokler's grant